| Dr Samuel Blake Ecker, DO | |
|
204 Mccollum St Ste 106e, Laramie, WY 82070-5151 | |
| (970) 682-3377 | |
| (970) 682-3340 |
| Full Name | Dr Samuel Blake Ecker |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 11 Years |
| Location | 204 Mccollum St Ste 106e, Laramie, Wyoming |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033555230 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 6858A (Wyoming) | Secondary |
| 207N00000X | Dermatology | 0061328 (Colorado) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sage Dermatology Llc | 2365840824 | 5 |
| Sage Dermatology Llc | 2365840824 | 5 |
News Archive
CQ HealthBeat: "The medical device industry told the Centers for Medicare and Medicaid Services that it's concerned about whether accountable care organizations could give providers financial incentives to hold back on needed patient care, particularly on technology. Meanwhile, insurance plan executives warned CMS officials that the ACOs could give hospitals and doctors new bargaining leverage in negotiations with insurers.
Primary Sclerosing Cholangitis (PSC) is a rare, chronic inflammatory disease of the bile ducts and is difficult to treat. Studies conducted by the Division of Gastroenterology and Hepatology at MedUni Wien under the guidance of Michael Trauner (Department of Internal Medicine III) were able to show positive effects from the administration of synthetically produced bile acids and bile acid receptor agonists.
Johns Hopkins Medicine researchers have added to evidence that a gene responsible for turning off a cell's natural "suicide" signals may also be the culprit in making breast cancer and melanoma cells resistant to therapies that use the immune system to fight cancer.
Successfully monitoring the distribution and fate of transplanted stem cells through imaging and subsequent tracking would aid clinicians in their ability to evaluate the efficacy of transplanted cells.
Underwood-Memorial Hospital of Woodbury, New Jersey has joined the Jefferson Neuroscience Network (JNN) as one of the first New Jersey participants. Through this collaboration, Jefferson and Underwood will provide some of the most sophisticated care and expertise available to patients with time-sensitive neurovascular diseases.
› Verified 5 days ago
| Entity Name | Sage Dermatology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255002101 PECOS PAC ID: 2365840824 Enrollment ID: O20211013002764 |
News Archive
CQ HealthBeat: "The medical device industry told the Centers for Medicare and Medicaid Services that it's concerned about whether accountable care organizations could give providers financial incentives to hold back on needed patient care, particularly on technology. Meanwhile, insurance plan executives warned CMS officials that the ACOs could give hospitals and doctors new bargaining leverage in negotiations with insurers.
Primary Sclerosing Cholangitis (PSC) is a rare, chronic inflammatory disease of the bile ducts and is difficult to treat. Studies conducted by the Division of Gastroenterology and Hepatology at MedUni Wien under the guidance of Michael Trauner (Department of Internal Medicine III) were able to show positive effects from the administration of synthetically produced bile acids and bile acid receptor agonists.
Johns Hopkins Medicine researchers have added to evidence that a gene responsible for turning off a cell's natural "suicide" signals may also be the culprit in making breast cancer and melanoma cells resistant to therapies that use the immune system to fight cancer.
Successfully monitoring the distribution and fate of transplanted stem cells through imaging and subsequent tracking would aid clinicians in their ability to evaluate the efficacy of transplanted cells.
Underwood-Memorial Hospital of Woodbury, New Jersey has joined the Jefferson Neuroscience Network (JNN) as one of the first New Jersey participants. Through this collaboration, Jefferson and Underwood will provide some of the most sophisticated care and expertise available to patients with time-sensitive neurovascular diseases.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Samuel Blake Ecker, DO 2710 Westridge Ct, Fort Collins, CO 80526-6503 Ph: (970) 682-3377 | Dr Samuel Blake Ecker, DO 204 Mccollum St Ste 106e, Laramie, WY 82070-5151 Ph: (970) 682-3377 |
News Archive
CQ HealthBeat: "The medical device industry told the Centers for Medicare and Medicaid Services that it's concerned about whether accountable care organizations could give providers financial incentives to hold back on needed patient care, particularly on technology. Meanwhile, insurance plan executives warned CMS officials that the ACOs could give hospitals and doctors new bargaining leverage in negotiations with insurers.
Primary Sclerosing Cholangitis (PSC) is a rare, chronic inflammatory disease of the bile ducts and is difficult to treat. Studies conducted by the Division of Gastroenterology and Hepatology at MedUni Wien under the guidance of Michael Trauner (Department of Internal Medicine III) were able to show positive effects from the administration of synthetically produced bile acids and bile acid receptor agonists.
Johns Hopkins Medicine researchers have added to evidence that a gene responsible for turning off a cell's natural "suicide" signals may also be the culprit in making breast cancer and melanoma cells resistant to therapies that use the immune system to fight cancer.
Successfully monitoring the distribution and fate of transplanted stem cells through imaging and subsequent tracking would aid clinicians in their ability to evaluate the efficacy of transplanted cells.
Underwood-Memorial Hospital of Woodbury, New Jersey has joined the Jefferson Neuroscience Network (JNN) as one of the first New Jersey participants. Through this collaboration, Jefferson and Underwood will provide some of the most sophisticated care and expertise available to patients with time-sensitive neurovascular diseases.
› Verified 5 days ago